Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation (Q56903658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

main subject

liver transplantation

1 reference

4

Patrick Boor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Philip de Reuver

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Vera Pravica

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Wim Hop

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Herold J Metselaar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ian V Hutchinson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hugo W Tilanus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jaap Kwekkeboom

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1587-1594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

The role of T-cell costimulatory activation pathways in transplant rejection

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

CTLA-4 up-regulation plays a role in tolerance mediated by CD45.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Tracking the immunoregulatory mechanisms active during allograft tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Detection of a polymorphism in exon 8 of the human CD86 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Cytokine gene polymorphisms and acute human liver graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6135.2003.00261.X

10.1046/J.1600-6135.2003.00261.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14629291%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference